RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Cytokine-suppressive activity of a hydroxylated alkylamide from Echinacea purpurea
Leyte-Lugo, M., Todd, D., Gulledge, T., Juzumaite, M., Carter, F., Laster, S., & Cech, N. (2015). Cytokine-suppressive activity of a hydroxylated alkylamide from Echinacea purpurea. Planta Medica Letters, 2(01), e25-e27. https://doi.org/10.1055/s-0035-1557764
Echinacea purpurea has been widely used to treat upper respiratory tract infections. Bioassay-guided fractionation of hexane and ethanol extracts of this plant yielded 4[(2-methylbutyl)amino]-4-oxo-2-butenoic acid (1) and 8,11-dihidroxy-dodeca-2E,4E,9E-trienoic acid isobutylamide (2), both of which are new to Echinacea. Compound 2 suppressed the production of TNF-α from RAW 264.7 cells with an IC50 value of 6.8 µM, while 1 was inactive. Neither compound showed cytotoxicity at concentrations up to 100 µM. These findings support a growing body of literature demonstrating that E. purpurea contains an array of compounds that suppress cytokine secretion by macrophage-type cells in vitro.
